©2013 National Research Council of Thailand
Manthana Mitchai. 2013. Natural killer cells status in human immunodeficiency virus (HIV) infected patients under highly active antiretroviral therapy (HAART) and the development of therapeutic agent for HIV -associated primary effusion lymphome (PEL). , Department of Hematopoiesis Center for AIDS Research Kumamoto University Japan;
Manthana Mitchai. (2013) Natural killer cells status in human immunodeficiency virus (HIV) infected patients under highly active antiretroviral therapy (HAART) and the development of therapeutic agent for HIV -associated primary effusion lymphome (PEL) . Department of Hematopoiesis Center for AIDS Research Kumamoto University Japan/Japan.
Manthana Mitchai. Natural killer cells status in human immunodeficiency virus (HIV) infected patients under highly active antiretroviral therapy (HAART) and the development of therapeutic agent for HIV -associated primary effusion lymphome (PEL). . Japan:Department of Hematopoiesis Center for AIDS Research Kumamoto University Japan, 2013.
Manthana Mitchai. (2013) Natural killer cells status in human immunodeficiency virus (HIV) infected patients under highly active antiretroviral therapy (HAART) and the development of therapeutic agent for HIV -associated primary effusion lymphome (PEL) . Department of Hematopoiesis Center for AIDS Research Kumamoto University Japan/Japan.